Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Real Madrid will suspend contract negotiations with the defender until the end of the season

Real Madrid have finally given significant minutes to a youth product this season, with centre-back Raúl Asencio threatening to be the first La Fábrica product to break into the first team since Lucas Vázquez or Dani Carvajal. The whites intend to renew his contract.

Initial contacts have already been made with their agents, Relevo says, but no new deals are expected soon. Talks will continue from 2025 and are likely to conclude only towards the end of this season, which is standard practice for their academy talents. Real Madrid are delighted with their progress and president Florentino Pérez in particular likes what he has seen.

He will not be part of the Castilla squad next season, that’s for sure. Asencio could earn a living in the senior team next season, or he could be sold, with a percentage of selling fee included, like Rafa Marín, Nico Paz or Sergio Arribas recently. Asencio is also not in a hurry to renew and, regardless of the interest that comes, he will give priority to the whites. His current contract expires in 2026.

Recent history would suggest that Real Madrid are looking for a healthy profit for Asencio rather than a long-term future in the first team. It won’t help that Carlo Ancelotti tends to favor more experienced options over younger players. Likewise, Real Madrid has an increasingly smaller number of players who have gone through its youth system and the Spanish quarries, and is aware that it needs a minimum for the European competition squads.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.